Clinical Operations Manager, Finance, Budgets and Contracts, FSP

Job overview

The Clinical Operations Manager, Finance role is listed in Indianapolis, IN, and the posting does not specify compensation. The position supports Parexel's country clinical operations and study start-up work. It oversees assigned protocol performance and compliance and manages budget and finance aspects of clinical trial submissions and site readiness. The manager coordinates country deliverables, timelines, budgets, contracts, and payments with clinical, finance, legal, regulatory, and site partners. The role helps ensure clinical trials meet country commitments and applicable quality, regulatory, and financial requirements.

What you'll do

• Manage country deliverables, timelines, and results for assigned protocols
• coordinate with clinical research managers, associates, coordinators, finance, and legal teams
• support submissions, budgets, clinical trial research agreements, and local milestones
• coordinate local vendors, supplies, import/export requirements, filing, archiving, and insurance processes
• develop, negotiate, and complete country and site budgets and agreements
• track clinical research payments and reconciliation
• support financial compliance and forecasting
• contribute to team knowledge, training, and mentoring.

What we're looking for

Skills & competencies

clinical operations manager

finance

budgets and contracts

fsp

parexel

clinical trials

study start-up

country operations

site budgets

clinical trial agreements

regulatory submissions

payment reconciliation

indianapolis in

Work arrangement

• Weekend coverage required

Why this role

The description identifies this as a Clinical Operations Manager Finance role. Requires knowledge of budget and contract negotiations and the local regulatory environment; minimal travel is required. The role may work effectively in a remote virtual environment.

About the employer

Parexel is hiring for this role. Industry: Research and Development in Biotechnology (except Nanobiotechnology). Sector: 54.